The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...
The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.
American pharmaceutical company Moderna (MRNA) is reportedly under scrutiny by U.S. President Donald Trump’s team, which is ...
A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being ...
Moderna is one of the pharmaceutical companies best known for developing the messenger RNA vaccine against Covid-19.
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...
The U.S. government awarded Moderna $590 million in January to advance the development of its bird flu vaccine ...
U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna (NASDAQ:MRNA) by the ...
Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...
The Department of Health and Human Services is re-evaluating a $590 million contract for avian influenza mRNA vaccines that ...
US health officials are reportedly reexamining a $590 million agreement awarded to Moderna (Nasdaq: MRNA) for the development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results